100 related articles for article (PubMed ID: 7768064)
1. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
Shen GX; Mymin D; Dembinski T; Krahn A; Angel A
Clin Invest Med; 1995 Feb; 18(1):33-41. PubMed ID: 7768064
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) plasma concentrations, apolipoprotein (a) polymorphism and family history of coronary heart disease in patients with essential hypertension.
Gazzaruso C; Buscaglia P; Garzaniti A; Bonetti G; Savino S; Mariotti S; Jucci A; Finardi G; Geroldi D
J Cardiovasc Risk; 1996 Apr; 3(2):191-7. PubMed ID: 8836862
[TBL] [Abstract][Full Text] [Related]
3. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.
Ducas J; Silversides C; Dembinski TC; Chan MC; Tate R; Dick A; Nixon P; Ren S; Shen GX
Clin Invest Med; 2002 Jun; 25(3):74-82. PubMed ID: 12137255
[TBL] [Abstract][Full Text] [Related]
5. Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease.
Dirisamer A; Widhalm H; Aldover-Macasaet E; Molzer S; Widhalm K
Acta Paediatr; 2008 Dec; 97(12):1653-7. PubMed ID: 18684164
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease.
Peros E; Geroldi D; D'Angelo A; Falcone C; Montagna L; Carabela M; Emanuele E
Int J Mol Med; 2004 Feb; 13(2):243-7. PubMed ID: 14719130
[TBL] [Abstract][Full Text] [Related]
7. Genetics of apolipoprotein B and apolipoprotein AI and premature coronary artery disease.
Zambon A; Brown BG; Deeb SS; Brunzell JD
J Intern Med; 2006 May; 259(5):473-80. PubMed ID: 16629853
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein(a) size polymorphism is associated with coronary heart disease in polygenic hypercholesterolemia.
Emanuele E; Peros E; Minoretti P; D'Angelo A; Piccinni MN; Montagna L; Geroldi D
Nutr Metab Cardiovasc Dis; 2004 Aug; 14(4):193-9. PubMed ID: 15553596
[TBL] [Abstract][Full Text] [Related]
9. Subclasses of low-density lipoprotein and very low-density lipoprotein in familial combined hyperlipidemia: relationship to multiple lipoprotein phenotype.
Georgieva AM; van Greevenbroek MM; Krauss RM; Brouwers MC; Vermeulen VM; Robertus-Teunissen MG; van der Kallen CJ; de Bruin TW
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):744-9. PubMed ID: 14751815
[TBL] [Abstract][Full Text] [Related]
10. Genetics and cardiovascular risk: a role for apolipoprotein(a) polymorphism.
Gazzaruso C; Garzaniti A; Geroldi D; Finardi G
Cardiologia; 1999 Apr; 44(4):347-54. PubMed ID: 10371786
[TBL] [Abstract][Full Text] [Related]
11. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
[TBL] [Abstract][Full Text] [Related]
12. [Apolipoprotein(a) phenotypes as markers of genetic susceptibility for cardiovascular risk in occupational medicine].
Mennoia NV; Gazzaruso C; Geroldi D; Candura SM
G Ital Med Lav Ergon; 1999; 21(3):206-17. PubMed ID: 10771732
[TBL] [Abstract][Full Text] [Related]
13. [Effects of pravastatin on serum lipids, apoproteins, and lipoprotein (a) in primary hypercholesterolemia].
Galetta F; Sampietro T; Basta G; Bionda A
Minerva Med; 1994 Jun; 85(6):321-6. PubMed ID: 8084435
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein(a), apolipoprotein(a) polymorphism and coronary atherosclerosis severity in type 2 diabetic patients.
Gazzaruso C; Bruno R; Pujia A; De Amici E; Fratino P; Solerte SB; Garzaniti A
Int J Cardiol; 2006 Apr; 108(3):354-8. PubMed ID: 15961173
[TBL] [Abstract][Full Text] [Related]
15. Familial hypercholesterolemia and familial defective apolipoprotein B-100: comparison of the phenotypic expression In 116 cases.
Brugger D; Schuster H; Zöllner N
Eur J Med Res; 1996 May; 1(8):383-6. PubMed ID: 9360938
[TBL] [Abstract][Full Text] [Related]
16. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus.
Peros E; Geroldi D; Bugatti S; Caporali R; Rossi P; Montecucco C; D'Angelo A; Emanuele E
Int J Mol Med; 2005 Apr; 15(4):661-5. PubMed ID: 15754029
[TBL] [Abstract][Full Text] [Related]
18. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
Liu X; Sun L; Li Z; Gao Y; Hui R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein(a) isoform-specific changes of lipoprotein(a) after kidney transplantation.
Kronenberg F; Lhotta K; König P; Margreiter R; Dieplinger H; Utermann G
Eur J Hum Genet; 2003 Sep; 11(9):693-9. PubMed ID: 12939656
[TBL] [Abstract][Full Text] [Related]
20. Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.
Gazzaruso C; Garzaniti A; Buscaglia P; Bonetti G; Falcone C; Fratino P; Finardi G; Geroldi D
J Am Coll Cardiol; 1999 Jan; 33(1):157-63. PubMed ID: 9935023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
